Consequently, to functionally assess the self‐renewal potential of both the CLEC12A positive CD34+CD38− cells and the CD34+CD38− cells lacking CLEC12A expression, four MDS patients with known clonal cytogenetic abnormalities were selected for studies in the LTC‐IC assay. The gene discussed is CLEC12A; the disease is myelodysplastic syndrome.